Xiangjun He

机构：Hangzhou DAC Biotech (China)

发表论文 5 篇 · 总被引 67 次 · h-index 3

代表论文

• CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells (2025 · Cell Reports Medicine · 被引 46)
• Off-the-Shelf, Multiplexed-Engineered iPSC-Derived CD33 CAR-NK Cells for Treatment of Acute Myeloid Leukemia (2022 · Blood · 被引 10)
• Regulatable C-X-C chemokine receptor type 4 in iPSC-derived NK cells improves bone marrow chemotaxis and targeting resident tumor (2025 · Trends in biotechnology · 被引 9)
• Abstract 3155: "Super NK cells" - natural killer cells derived from engineered hiPSC with enhanced NK receptor expression demonstrate better anti-tumor effects for solid tumors (2022 · Cancer Research · 被引 1)
• Abstract 6070: Functional natural killer cells derived from engineered hiPSC with hypoimmunity gene combo demonstrate hypoimmunity features in evading host attacks (2022 · Cancer Research · 被引 1)